Trending News
News
News
onCore UK Licenses LabVantage's Sapphire™ BioBanking Solution to Support its Ambitious Cancer Biosample Resource
onCore UK will create and run a national biosample resource, collecting and storing tissue and blood samples donated by patients.
News
Kimball Genetics Launches the Warfarin Sensitivity DNA Test for Research
The Warfarin Sensitivity DNA Test determines the presence of specific variations in the CYP2C9 and VKORC1 genes that confer sensitivity to warfarin.
News
Genzyme Launches Cystic Fibrosis Gene Sequencing Test
CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
News
Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer
The trial will enroll patients with previously untreated, advanced or recurrent pancreatic cancer and a mutation in the BRCA2 gene.
News
TranSenda Announces Membership in BioIT Alliance
As a member of the BioIT Alliance, TranSenda will work in partnership with other science and technology industry leaders.
News
AviaraDx Announces Publication of Study with Baylor College of Medicine
The study demonstrates a two-gene ratio is a prognostic indicator of breast cancer recurrence risk.
News
Genomic Tests Guide Choice of Chemotherapy in Cancer Patients
The tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy.
News
Xenomics Announces Development of a Method for Isolation of Cell-Free Nucleic Acids From Urine
Prototype research kits approach commercialization phase and target the growing field of genomic-based molecular diagnostics.
News
Ciphergen Announces Data Supporting the use of Protein Biomarkers to Improve Patient Diagnosis for Ovarian Cancer
The study reproduced findings from an earlier study in an independent study population, using proteomic profiling based on SELDI technology.
News
Relative Genetics Announces Advanced Maternal Lineage DNA Testing Services
The testing services offer complete Mitochondrial DNA sequencing results commercially available.
Advertisement